KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Basic) (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of EPS (Basic) data on record, last reported at $3.1 in Q4 2025.

  • For Q4 2025, EPS (Basic) rose 16.98% year-over-year to $3.1; the TTM value through Dec 2025 reached $13.17, up 22.28%, while the annual FY2025 figure was $13.17, 22.28% up from the prior year.
  • EPS (Basic) reached $3.1 in Q4 2025 per IDXX's latest filing, down from $3.43 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $3.66 in Q2 2025 and bottomed at $1.57 in Q2 2022.
  • Average EPS (Basic) over 5 years is $2.55, with a median of $2.5 recorded in 2023.
  • Peak YoY movement for EPS (Basic): soared 82.44% in 2021, then crashed 33.76% in 2022.
  • A 5-year view of EPS (Basic) shows it stood at $1.92 in 2021, then rose by 8.33% to $2.08 in 2022, then rose by 12.5% to $2.34 in 2023, then grew by 13.25% to $2.65 in 2024, then rose by 16.98% to $3.1 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Basic) were $3.1 in Q4 2025, $3.43 in Q3 2025, and $3.66 in Q2 2025.